Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

Emerging Infectious Diseases

Volumn 8, Issue 10, 2002, Pages 1103-1110

  Quinn, Conrad P ^a   Semenova, Vera A ^a   Elie, Cheryl M ^a   Romero Steiner, Sandra ^b   Greene, Carolyn ^a   Li, Han ^a   Stamey, Karen ^a   Steward Clark, Evelene ^a   Schmidt, Daniel S ^a   Mothershed, Elizabeth ^a   Pruckler, Janet ^a   Schwartz, Stephanie ^a   Benson, Robert F ^a   Helsel, Leta O ^a   Holder, Patricia F ^a   Johnson, Scott E ^a   Kellum, Molly ^a   Messmer, Trudy ^a   Lanier Thacker, W ^a   Besser, Lilah ^a   Plikaytis, Brian D ^a   Taylor Jr , Thomas H ^a   Freeman, Alison E ^a   Wallace, Kelly J ^a   Dull, Peter ^a   Sejvar, Jim ^a   Bruce, Erica ^a   Moreno, Rosa ^a   Schuchat, Anne ^a   Lingappa, Jairam R ^a   Martin, Sandra K ^a   Walls, John ^a   Bronsdon, Melinda ^a   Carlone, George M ^a   Bajani Ar, Mary ^a   Ashford, David A ^a   Stephens, David S ^a   Perkins, Bradley A ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; IMMUNOGLOBULIN G ANTIBODY;

ANTHRAX; ARTICLE; COMPETITIVE INHIBITION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; LABORATORY TEST; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0036775247     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0810.020380     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Human anthrax associated with an epizootic among livestock - North Dakota, 2000. MMWR Morb Mortal Wkly Rep 2001;50:677-80.
2. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Anthrax as a biological weapon. JAMA 2002;287:2236-52.
3. Centers for Disease Control and Prevention. Update: Cutaneous anthrax in a laboratory worker - Texas, 2002. MMWR Morb Mortal Wkly Rep 2002;51:482.
4. Leppla SH. Purification and characterization of adenylyl cyclase from Bacillus anthracis. In: Johnson A, Corbin JD. Methods in enzymology. Vol 195. San Diego: Academic Press; 1991. p. 153-68.
5. Reimer CB, Smith SJ, Wells TW, Nakamura RM, Keitges PW, Ritchie RF, et al. Collaborative calibration of the U.S. National and the College of American Pathologists reference preparation for specific serum proteins. Am J Clin Pathol 1982;77:12-9.
6. 197 conjugate vaccine in infants aged 15 to 23 months. Pediatrics 1990;86:527-34.
7. Plikaytis BD, Holder PF, Carlone GM. Program ELISA for Windows User's Manual, Version 1.00. Atlanta: Centers for Disease Control and Prevention; 1996.
8. Romero-Steiner S, Elie CM, Holder PF, Semenova V, Helsel L, Thacker L, et al. Specificity of a standardized Bacillus anthracis ELISA for measurement of anti-protective antigen IgG antibodies in human sera from individuals diagnosed with cutaneous anthrax. Abstracts of the 4th International Conference on Emerging Infectious Diseases, April 27-30, 2002, Atlanta GA. ICEIDL-667.
9. O'Connell MA, Belanger BA, Haaland PD. Calibration and assay development using the four-parameter logistic model. Chemometrics and Intelligent Laboratory Systems 1993;20:97-114.
10. Plikaytis BD, Turner SH, Gheesling LL, Carlone GM. Comparisons of standard curve fitting methods to quantitate Neisseria meningitidis Group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J Clin Microbiol 1991;29:1439-46.
11. Jacobson RH. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech 1998;17:469-526.
12. Plikaytis BD, Holder PF, Pais LB, Maslanka SE, Gheesling LL, Carlone GM. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol 1994;32:2441-7.
13. Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, et al. Opening a Bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: The public health response. Emerg Infect Dis 2002;8:1039-43.
14. Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002;8:1066-72.
15. Shlyakhov E, Rubinstein E. Evaluation of the Anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis 1996;15:242-5.
16. Turnbull PCB, Doganay M, Lindeque PM, Aygen B, McLaughlin J. Serology and anthrax in humans, livestock and Etosha National Park wildlife. Epidemiol Infect 1992;108:299-313.
17. Sirisanthana T, Nelson KE, Ezzell JW, Abshire TG. Serological studies of patients with cutaneous and oropharyngeal anthrax from northern Thailand. Am J Trop Med Hyg 1988;39:575-81.
18. Harrison LH, Ezzell JW, Veterinary Laboratory Investigation Center, Abshire TG, Kidd S, Kaufman A. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis 1989;160:706-10.
19. Shlyakhov EN, Shvarts SA, Gruz EV. Diagnosis of anthrax by means of Anthraxin. J Hyg Epidemiol Microbiol Immunol 1973;17:279-84.
20. Pfisterer RM. Retrospective verification of the diagnosis of anthrax by means of the intracutaneous skin test with the Russian allergen "Anthraxin" in a recent epidemic in Switzerland. Salisbury Medical Bulletin (Special Supplement) 1990;68:80.
21. Kleine-Albers C, Hönicke E, Böhm R, Pfisterer RM. The detection of antibodies against the protective antigen of Bacillus anthracis in infected persons by enzyme-immunoassay (EIA). Salisbury Medical Bulletin (Special Supplement) 1990;68:75-6.
22. Darlow HM, Pride NB. Serological diagnosis of anthrax. Lancet 1969;2:430.
23. Buchanan TM, Feeley JC, Hayes PS, Brachman PS. Anthraxin direct microhemagglutination test. J Immunol 1971;107:1631-6.
24. Strange RE, Thorne CB. Further studies on the protective antigen of Bacillus anthracis produced in vitro. J Bacteriol 1958;76:192-202.
25. Johnson-Winegar A. Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies. J Clin Microbiol 1984;20:357-61.
26. Iacono-Connors LC, Novak J, Rossi C, Mangiafico J, Ksiazek T. Enzyme-linked immunosorbent assay using a recombinant baculovirusexpresses Bacillus anthracis protective antigen (PA): Measurement of human anti-PA antibodies. Clin Diagn Lab Immunol 1994;1:78-82.
27. Turnbull PCB, Leppla SH, Broster MG, Quinn CP, Melling J. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med Microbiol Immunol 1988;177:293-303.
28. Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little S, et al. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 2002;20:1412-20.
29. Turnbull PCB, Broster M, Carman AJ, Manchee RJ, Melling J. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun 1986;52:356-63.
30. Jernigan J, Stephens D, Ashford D, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-44.
31. Jacobson RH. How well do serodiagnostic tests predict the infection or disease status of cats. J Am Vet Med Assoc 1991;199:1343-7.
32. Woo PCY, Tsoi H-W, Won L-P, Leung HC, Yuen K-Y. Antibiotics modulate vaccine-induced humoral immune response. Clin Diagn Lab Immunol 1999;6:832-7.
33. Friedlander AM, Welkos SL, Pitt ML, Ezzell JW, Worsham PL, Rose KJ, et al. Post exposure prophylaxis against experimental inhalational anthrax. J Infect Dis 1993;167:1239-42.